BB-05-NK66_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, [(3R)-1-[2-(1,2-oxazol-3-ylamino)-2-oxoethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate (Novartis, 87456973)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/87456973
Similar Terms
Downloads & Tools

Genes

18 genes differentially expressed following the BB-05-NK66_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
GAPDH glyceraldehyde-3-phosphate dehydrogenase 5.29991
PQBP1 polyglutamine binding protein 1 2.54731
TMSB10 thymosin beta 10 1.76161
RPL28 ribosomal protein L28 1.51627
S100A2 S100 calcium binding protein A2 0.859469
TRAP1 TNF receptor-associated protein 1 0.792592
RRP9 ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast) 0.665631
S100A6 S100 calcium binding protein A6 0.64286
RPS24 ribosomal protein S24 0.516647
BAG6 BCL2-associated athanogene 6 0.35778
UPP1 uridine phosphorylase 1 0.314233
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.273783
CRYAB crystallin, alpha B 0.271991
OSBPL11 oxysterol binding protein-like 11 0.263317
S100A11 S100 calcium binding protein A11 0.215166
ARF1 ADP-ribosylation factor 1 0.200765
OAZ1 ornithine decarboxylase antizyme 1 0.200765

decreased expression

Symbol Name Standardized Value
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.215343